Retrotransposons as site-specific gene delivery vectors
逆转录转座子作为位点特异性基因递送载体
基本信息
- 批准号:6623503
- 负责人:
- 金额:$ 11.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-01 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:Animalia RNA directed DNA polymerase biotechnology chemical structure function endonuclease gene delivery system gene expression gene targeting gene therapy immunoregulation intermolecular interaction molecular site nucleic acid repetitive sequence nucleic acid structure protein engineering recombinant DNA recombinant proteins technology /technique development transfection /expression vector transposon /insertion element
项目摘要
DESCRIPTION (provided by applicant): L1 retrotransposons are mobile DNA
elements which move by a copy and paste mechanism and show no strong insertion
site preference. Preliminary studies have shown that Lis can deliver attached
reporter genes into the DNA of human cells in culture and that these genes can
be expressed. Such studies suggest that the L1 might be utilized as a gene
transfer vector having several advantages over other gene therapy vectors
currently in preclinical and clinical trials.
This proposal is designed to explore strategies for modifying the L1
retrotransposon to produce a gene delivery vector which can target to specific
sequences in the human genome. This may be accomplished by replacing the L1
endonuclease domain with endonuclease domains from site-specific
retrotransposons of other species, including the R1 element of insects and the
Tx1L element from Xenopus, or by linking the L1 endonuclease domain to
site-specific binding motifs (eg. GAL4 binding domain, zinc finger domains). I
also will test the ability of wild-type R1, R2, and Tx1L elements to
retrotranspose in human cells and will consider their direct application as
gene delivery vectors. In addition, I will assay in cell culture the efficiency
of the L1 at integrating increasing lengths of exogenous DNA.
描述(申请人提供):L1反转录转座子是可移动的DNA
通过复制和粘贴机制移动且没有强烈插入的元素
站点首选项。初步研究表明,LIS可以将附件
报告基因进入培养的人类细胞的DNA中,这些基因可以
被表达出来。这些研究表明,L1可能被用作一种基因
转移载体与其他基因治疗载体相比有几个优点
目前正在进行临床前和临床试验。
本提案旨在探讨修改L1的策略
反转录转座子产生靶向特定靶点的基因传递载体
人类基因组中的序列。这可以通过更换L1
具有来自特定位点的核酸内切酶结构域的核酸内切酶结构域
其他物种的反转录转座子,包括昆虫的R1元件和
Tx1L元件,或通过将L1内切酶结构域连接到
特定部位的结合基序(例如GAL4结合结构域、锌指结构域)。我
还将测试野生型R1、R2和Tx1L元件的能力
逆转座子在人类细胞中的应用,并将其直接应用于
基因传递载体。此外,我还将在细胞培养中检测其效率
L1的外源DNA的整合长度增加。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN Lawrence GOODIER其他文献
JOHN Lawrence GOODIER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN Lawrence GOODIER', 18)}}的其他基金
Retrotransposition independent LINE 1-induced DNA damage in normal and aging cells
正常细胞和衰老细胞中不依赖逆转录转座的 LINE 1 诱导的 DNA 损伤
- 批准号:
9766167 - 财政年份:2018
- 资助金额:
$ 11.89万 - 项目类别:
A role for endogenous retroelements in Aicardi-Goutieres Syndrome
内源性逆转录因子在 Aicardi-Goutieres 综合征中的作用
- 批准号:
9296176 - 财政年份:2016
- 资助金额:
$ 11.89万 - 项目类别:
Exploring a role for LINE1 retrotransposons in neurodegenerative disease
探索 LINE1 逆转录转座子在神经退行性疾病中的作用
- 批准号:
8678465 - 财政年份:2014
- 资助金额:
$ 11.89万 - 项目类别:
Exploring a role for LINE1 retrotransposons in neurodegenerative disease
探索 LINE1 逆转录转座子在神经退行性疾病中的作用
- 批准号:
8805859 - 财政年份:2014
- 资助金额:
$ 11.89万 - 项目类别:
Retrotransposons as site-specific gene delivery vectors
逆转录转座子作为位点特异性基因递送载体
- 批准号:
6466397 - 财政年份:2002
- 资助金额:
$ 11.89万 - 项目类别:
相似海外基金
RNA DIRECTED DNA POLYMERASE & 70S RNA OF ONCORNAVIRUSES
RNA定向DNA聚合酶
- 批准号:
3164921 - 财政年份:1980
- 资助金额:
$ 11.89万 - 项目类别:
RNA DIRECTED DNA POLYMERASE & 70S RNA OF ONCORNAVIRUSES
RNA定向DNA聚合酶
- 批准号:
2086700 - 财政年份:1980
- 资助金额:
$ 11.89万 - 项目类别:
RNA-DIRECTED DNA POLYMERASE & 70S RNA OF ONCORNAVIRUSES
RNA引导的DNA聚合酶
- 批准号:
3164920 - 财政年份:1980
- 资助金额:
$ 11.89万 - 项目类别:
RNA DIRECTED DNA POLYMERASE & 70S RNA OF ONCORNAVIRUSES
RNA定向DNA聚合酶
- 批准号:
3164916 - 财政年份:1980
- 资助金额:
$ 11.89万 - 项目类别:
RNA DIRECTED DNA POLYMERASE & 70S RNA OF ONCORNAVIRUSES
RNA定向DNA聚合酶
- 批准号:
3164922 - 财政年份:1980
- 资助金额:
$ 11.89万 - 项目类别:
RNA-DIRECTED DNA POLYMERASE & 70S RNA OF ONCORNAVIRUSES
RNA引导的DNA聚合酶
- 批准号:
3164919 - 财政年份:1980
- 资助金额:
$ 11.89万 - 项目类别:
RNA DIRECTED DNA POLYMERASE & 70S RNA OF ONCORNAVIRUSES
RNA定向DNA聚合酶
- 批准号:
3164923 - 财政年份:1980
- 资助金额:
$ 11.89万 - 项目类别:
RNA-DIRECTED DNA POLYMERASE & 70S RNA OF ONCORNAVIRUSES
RNA引导的DNA聚合酶
- 批准号:
3164918 - 财政年份:1980
- 资助金额:
$ 11.89万 - 项目类别: